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Ferran Velasco-Mallorquí1,3, Júlia Rodríguez-Comas1,3 and Javier Ramón-Azcón1,2,∗
1 Biosensors for Bioengineering, Institute for Bioengineering of Catalonia (IBEC), The Barcelona Institute of Science and Technology
(BIST), Baldiri I Reixac, 10-12, Barcelona 08028, Spain
2 ICREA-Institució Catalana de Recerca i Estudis Avançats, 08010 Barcelona, Spain
3 Authors contributed equally to this work.
∗ Author to whom any correspondence should be addressed.
Keywords: tissue engineering, biomaterial, scaffold, cryogel, β-cell, pancreatic islets
Supplementary material for this article is available online
Abstract
In vitro research for the study of type 2 diabetes (T2D) is frequently limited by the availability of a
functional model for islets of Langerhans. To overcome the limitations of obtaining pancreatic
islets from different sources, such as animal models or human donors, immortalized cell lines as
the insulin-producing INS1E β-cells have appeared as a valid alternative to model insulin-related
diseases. However, immortalized cell lines are mainly used in flat surfaces or monolayer
distributions, not resembling the spheroid-like architecture of the pancreatic islets. To generate
islet-like structures, the use of scaffolds appeared as a valid tool to promote cell aggregations.
Traditionally-used hydrogel encapsulation methods do not accomplish all the requisites for
pancreatic tissue engineering, as its poor nutrient and oxygen diffusion induces cell death. Here, we
use cryogelation technology to develop a more resemblance scaffold with the mechanical and
physical properties needed to engineer pancreatic tissue. This study shows that carboxymethyl
cellulose (CMC) cryogels prompted cells to generate β-cell clusters in comparison to gelatin-based
scaffolds, that did not induce this cell organization. Moreover, the high porosity achieved with
CMC cryogels allowed us to create specific range pseudoislets. Pseudoislets formed within
CMC-scaffolds showed cell viability for up to 7 d and a better response to glucose over
conventional monolayer cultures. Overall, our results demonstrate that CMC-scaffolds can be used
to control the organization and function of insulin-producing β-cells, representing a suitable
technique to generate β-cell clusters to study pancreatic islet function.
1. Introduction
The worldwide prevalence of type 2 diabetes (T2D)
has been increasing over the last decades, attaining
the status of a global pandemic [1]. T2D is a chronic
metabolic disorder characterized by hyperglycemia.
It usually occurs when the peripheral tissues can-
not effectively use the insulin that pancreas produces.
This situation leads to an increased insulin demand
and therefore the insulin-producing β-cells respond
by activating compensatory pathways to improve
their secretory capacity. Over time, β-cells are no
longer able to cope with the metabolic demands and
T2D develops [1].
In vitro research for the study of T2D is frequently
limited by the availability of a functional model for
islets of Langerhans. Pancreatic islets are respons-
ible for maintaining glucose homeostasis by secret-
ing the glucose-lowering hormone insulin and its ant-
agonist, glucagon. Cell lines are a suitable alternative
to model T2D in vitro and avoid human donor
material or primary mouse pancreatic islets. Both
mouse insulinoma MIN6 and rat insulinoma INS1E
cell lines are commonly used for in vitro research.
Nevertheless, INS1E cells have been reported to
present better responsiveness to glucose within the
physiological range and relatively high insulin content
[2, 3].
© 2021 The Author(s). Published by IOP Publishing Ltd
Biofabrication 13 (2021) 035044 F Velasco-Mallorquí et al
Monolayer cell cultures have been shown to func-
tion differently than cells in vivo, and results of in vitro
tests may not accurately reflect cell response occur-
ring in vivo [2]. Pancreatic islets are round-shaped
cell aggregations of around 100 µm in diameter.
Their size and shape determine their functionality,
crucial to orchestrate the metabolic adjustments [4].
Indeed, β-cell aggregations into pseudoislets have
been proven to represent a more suitable model to
study β-cell function, demonstrating a better biolo-
gical response than cultured monolayered cells [5, 6].
However, most of these studies use pseudoislets in
suspension, therefore not representing an accurate
image of the in vivo environment to study their
behavior [7, 8].
To solve this problem, biomaterials and tissue
engineering appeared as a valid alternative to gen-
erate 3D microenvironments. The use of scaffolds
has allowed the generation of a wide variety of 3D
environments that have enabled to better mimic the
in vivo situation of each tissue (e.g. skeletal muscle
[9, 10], intestine [11], or liver [12]). With this pur-
pose, hydrogel encapsulation has appeared as the
gold standard. This technique allows modulating the
external morphology (i.e. lines [10], pillars [11], or
meshes [13]), the stiffness, the pore size, or the bio-
chemical cues to promote cell attachment [14, 15] to
better fit with the needs of each engineered tissue.
However, this approach entails several drawbacks that
can end up in cell death. Exposure to the UV light
or other toxic crosslinking reagents [16] or the small
pore sizes (usually in the nanometer range) can lead
to insufficient nutrient diffusion, clumping prob-
lems, hypoxia, and difficulties inducing vasculariza-
tion [17, 18]. These limitationsmake this approxima-
tion non-suitable for all kinds of tissues. Additionally,
these problems become more detrimental when cell
aggregations are encapsulated [19, 20] and explicitly
challenging with β-cells, specialized cell types adap-
ted to sense rapid changes in glucose [21]. Therefore,
a perturbation of the glucose-sensing machinery in
these cells can entail a suboptimal insulin release.
Extensive efforts have been made to develop
the ideal scaffold to support these cells. Such scaf-
fold must be fabricated with biocompatible poly-
mers, suitable for mammalian cell growth. It must be
highly porous to allow adequate oxygen and nutri-
ent diffusion, and it also needs to be mechanically
stable, with the appropriate structure to avoid shear-
stress-induced cell damage [22]. With the inten-
tion to aggregate β-cells in a 3D microenvironment,
we engineered gelatin and carboxymethyl cellulose
(CMC)-based cryogels, which enabled us to design a
supportive material for the proliferation and growth
of β-cells.
Cryogels, are sponge-like scaffolds with micro-
meter pore range formed at sub-zero temperat-
ures [23]. This technique entails several advant-
ages compared to other approaches. It allows high
pore diameters [24], fundamental to precisely con-
trol cell aggregates diameters. Moreover, it provides
the mechanical support suitable to manipulate the
structure easily [25]. And finally, it enables cell seed-
ing after polymerization of the scaffold, therefore
avoiding exposure to harmful crosslinking reagents
or UV light. Additionally, both materials have been
reported to present excellent biocompatible proper-
ties [25, 26]. Gelatin is a derivate of collagen which
displays weak mechanical properties and presents the
tripeptide Arg-Gly-Asp (RGD), a cell-binding motif
[27]. On the other hand, CMC is a derivate com-
pound from cellulose, which has better mechanical
stability and good biocompatibility but without the
presence of cell-binding motifs [28].
In this study, INS1E cells were seeded onto 3D
gelatin and CMC scaffolds to investigate the substrate
architecture’s effect on the cell’s organization and
function.We examined cell viability and formation of
cell-clusters after 1, 4, and 7 d of culture, and we com-
pared them with cells seeded in a plate. CMC-based
scaffolds promoted the formation of INS1E aggreg-
ations into pseudoislets, whereas dispersed organ-
ization was observed in gelatin-based cryogels. We
also show that INS1E pseudoislets ameliorated their
response to glucose stimuli and presented a more
closely related mature β-cell phenotype than non-
organized cells seeded in gelatin-based cryogels or a
traditional well-plate.
Our results demonstrate that scaffold biomater-
ials can be used to control the organization and
enhance the function of insulin-producing β-cells.
These advantageous propertiesmake this approach an
ideal model for the study of pancreatic islet function,




CMC (Sigma Aldrich, Germany), or gelatin from
porcine skin (Sigma Aldrich, Germany) were diluted
into MilliQ water with stirring conditions at 45 ◦C.
Once the prepolymer solution is homogeneous,
the crosslinking reagents were prepared; MES buf-
fer from MES hydrate (Sigma Aldrich, Germany)
at 0.5 M and pH at 5.5, adipic acid dihydrazide
(AAD, Sigma Aldrich, Germany) at 50 mg ml−1, and
N-(3-dimethylaminopropyl)-N ′-ethylcarbodiimide
hydrochloride (EDC, Sigma Aldrich, Germany) at
1 µg µl−1 all dissolved in MilliQ water and vortexed
to ensure the homogeneity in all the solution. Pre-
polymer solution, 1 ml of the prepolymer, 50 mM
of MES buffer, 1.83 mM of AAD, and 18.9 µM
of EDC were added into a tube vigorously pipet-
ted, avoiding early crosslinking before freezing. For
stained cryogels, 10.9 µM fluoresceinamine (Sigma
Aldrich, Germany) was added to the final prepolymer
solution. Then polydimethylsiloxane (PDMS) molds
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were filled with the final prepolymer solution. These
molds consist of a PDMS pool with 1 mm high and
10 mm of diameter over a squared 24× 24 mm cover
glass. After filling, they were placed into a −20 ◦C
freezer for 24 h. The next day, the crosslinked cryo-
gels were removed carefully from the mold and then
submerged into consecutive 5 min cleaning steps;
1 × MilliQ water, 1 × 100 mM NaOH (Panreac,
Germany), 1 × 10 mM ethylenediaminetetraacetic
acid (EDTA, Sigma Aldrich, Germany), 1 × MilliQ
and 3 × phosphate buffered saline (PBS, 0.01 M
phosphate buffer, 0.0027 M potassium chloride and
0.137 M sodium chloride, pH 7.4, Sigma-Aldrich,
Germany). Once finished the cleaning protocol, the
cryogels were sterilized for further cell seeding exper-
iments in an autoclave.
2.2. Biomaterial characterization
2.2.1. Pore analysis
For the pore analysis, the fibers of the cryogel
were stained, adding 10.9 µM of fluoresceinamine.
Once stained, z-stack images were taken in a con-
focal microscope, and the different pore diameters
were quantified with ImageJ version 1.52b software
(National Institutes of Health).
Scanning electron microscopy (SEM) observa-
tions were performed with a NOVA NanoSEM 230
microscope at 10 kV. Before imaging, cryogel scaf-
folds were subjected to consecutive ethanol dehydra-
tion steps, washing the cryogels with ethanol 50%,
70%, 80%, 90%, 96% (x2), and 99.5%. Once all
the water was substituted for ethanol, ethanol was
replaced by CO2, performing a critical point dry step.
A final stage of carbon sputtering was done before
SEM images were taken.
2.2.2. Swelling
Swelling experiments were performed to calculate
the water uptake ratio by a cryogel. Cryogels were
fabricated as explained previously, and after steril-
izing, cryogels were dried at room temperature and
weighted. Next, cryogels were submerged into MilliQ
water for 24 h, when they reached equilibrium and






whereWeq is the weight in equilibrium andWd is the
dry weight. Three cryogels per condition were meas-
ured in this assay.
2.2.3. Stiffness
Compression assays were performed to determine
the stiffness of our samples. The compression assays
were performed in a Zwick Z0.5 TN instrument
(Zwick-Roell) with a 5 N load cell. The experiment
was performed with samples at room temperature up
to 30% final compression range at 0.1 mN of pre-
loading force and 20%/minute of strain rate. Finally,
the Young modulus was calculated from 10% to 20%
of compression from the line’s slope. In these exper-
iments, three measurements per cryogel and three
cryogels per condition were tested.
2.2.4. Permeability assay
Cryogels were placed over a transwell inside a 12 well-
plate. 500 ml of 1.5 mM fluorescein (Sigma Aldrich)
were added at the transwell’s upper compartment,
and 1.5 ml of PBS were added in the lower chamber.
100 µl of PBS from the well were taken out in consec-
utive times. The same amount of fresh PBS was added
to the lower compartment to readjust the volume.
This procedure was repeated during different times
up to an overnight when equilibrium was reached.
Finally, the concentration of fluorescein was obtained
by absorbance measurements at 494 nmwith a Power
wave X microplate spectrophotometer.
Permeability was calculated in the linear part of






where Q is the milligrams of fluorescein that pass
through the cryogel at a specific time, T is the time,
A is the area of the cryogel, and Co is the initial con-
centration of fluorescein. Finally, the permeability of
the cryogel was the difference between the total per-
meability and the permeability of the transwell.
2.3. Cell culture
Rat pancreatic β-cell line INS1E cells were cultured
in RPMI-1640 with 11.1 mM glucose, supplemen-
ted with 10 mM HEPES (Gibco), 2 mM L-glutamine
(Gibco), 1 mM sodium-pyruvate (Gibco), 0.05 mM
de 2-mercaptoethanol (Thermofisher), 10% fetal
bovine serum (FBS) (v/v) (Thermofisher) and 1%
penicillin/streptomycin (v/v) (Thermofisher) (com-
plete media). When cells reached confluency, cells
were trypsinized with 0.25 trypsin/0.1% EDTA and
plated in a new flask at 1:4 density. Cells were main-
tained in an incubator at 37 ◦C and 5% CO2.
2.4. Cell seeding
Cryogels were dried for 30 min. After trypsinization
of the cells, 200.000 cells mixed with a drop of 20 µl
of mediumwere seeded in each cryogel. After seeding
the cells, cryogels were left at room temperature (RT)
for 20 min, and a complete RPMI-1640 medium was




Viability assays were performed with the live/dead
assay kit (Thermofischer) according to manufacturer
instructions. The assays were performed at days 1,
4, and 7 of culture after seeding in traditional well
3
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plates and gelatin and CMC cryogels. Briefly, the
cryogels were washed 5 min with PBS three times to
replace culturemediumand incubatedwith thework-
ing solution (4 µM EthD-1, 2 µM Calcein AM, and
16.2 µMHoechst) for 25 min at 37 ◦C. Then cryogels
were washed three times with PBS. Finally, confocal
images were taken using a Zeiss LSM 800 confocal







AlamarBlue test was performed according to man-
ufacturer specifications. Briefly, the medium was
removed from the well plate and substituted for new
RPMI-1640 with 11.1 mM of glucose medium with
1:10 dilution of AlamarBlue. After 2 h incubation,
100 µl of each condition was placed in a well of 96
well-plate and read in a Power wave X microplate
spectrophotometer at 570 nm wavelength.
2.6. Immunostaining
For confocal analysis, stained cryogels were used.
After culturing the cells, cryogels were washed
with PBS and fixed with 10% formalin solution
(Sigma-Aldrich) for 30 min. Then, cryogels were
washed with tris buffered saline (TBS, Canvax
Biotech) and permeabilized with 0.1% Triton X-100
(v/v) (Sigma-Aldrich) solution in TBS for 15 min.
Cryogels were blocked with 0.5% Triton X-100 (v/v)
and 3% donkey serum (v/v) (Sigma-Aldrich) into
TBS for 2 h. Cryogels were incubated overnight
with primary antibodies against rabbit-anti Ki-67
(1:250, Invitrogen) and mouse anti-insulin (1:500,
Origene) in a blocking solution. The following day,
cryogels were washed with permeabilization solu-
tion and incubated with secondary antibodies for
2 h at room temperature (Alexa-Fluor 647 conjug-
ate anti-mouse 1:200 and Alexa-Fluor 568 conjugate
anti-rabbit 1:200, Invitrogen). DAPI (1:1000 Ther-
mofisher) was used to stain nuclei. Finally, cryogels
were washed with TBS for 15 min and stored at 4 ◦C
until confocal microscopy acquisition. Images were
taken using an LSM 800 from Zeiss.
2.7. Confocal microscopy
Different z-stacks were acquired for pore quantific-
ation, and pores were analyzed from images with
20 µm of z-gap between them. For quantification of
live/dead and proliferation assays, 20 images per cryo-
gel were taken and then analyzed. All images were
acquired using an LSM 800 from Zeiss.
2.8. Gene expression analysis
Total RNA was isolated from the sample cells using
the RNeasy MinElute cleanup kit (Qiagen) fol-
lowing the manufacturer’s instructions. Of total
RNA, 200 ng were used for reverse transcription
using high capacity cDNA reverse transcription kit
(Applied Biosystems). Quantitative PCR reactions
were run using SyberGreen (Invitrogen) in a 7900HT
fast real-time PCR system (Applied Biosystems) as
described elsewhere [29]. Primer sequences used for
gene expression analysis are listed in supplement-
ary table 1 (available online at stacks.iop.org/BF/13/
035044/mmedia). Tbp1 was used to normalize the
mRNA expression of genes of interest.
2.9. Glucose-stimulated insulin secretion (GSIS)
Cells seeded within the cryogels or in a well plate
were preincubated with Krebs-Ringer bicarbonate
HEPES buffer solution (115 mM NaCl, 24 mM
NaHCO3, 5 mMKCL, 1 mMMgCa2× 6H2O, 1 mM
CaCl2 × 2H2O and 20 mM HEPES, pH 7.4) con-
taining 2.8 mM glucose for 30 min. Then, cells were
incubated at low glucose (2.8 mM) for 1 h, followed
by incubation at high glucose (16.7mM) and an addi-
tional step at 2.8 mM. After each incubation step,
supernatants were collected, and cellular insulin con-
tents were recovered in acid-acetic lysis buffer (glacial
acetic acid 5.75%). Insulin concentrationwas determ-
ined by ELISA experiments.
2.10. ELISA (enzyme-linked immunoabsorbent
assay)
Briefly, mouse mAB insulin 26.6 nM of capture anti-
body (Novus) was diluted into coating buffer (0.05M
of sodium carbonate and sodium bicarbonate, pH
9.6) and placed into 96-well plate at 4 ◦C O/N.
Next, samples were placed into the plate, and a cal-
ibration curve, previously optimized, was performed.
After protein attachment into the primary antibody,
the biotinylated secondary anti-insulin antibody was
placed at 0.2 nM. Next, streptavidin was added at
4.73 nM (Thermo Scientific). Then, citrate buffer
(0.04 M sodium citrate, pH 5.4, 96 ug ml−1 of tet-
ramethylbenzidine and 0.004% of oxygen peroxide)
was added to start the reaction. Finally, 4 M sulfuric
acid was added to stop the reaction. The colorimetric
quantification was made with a Power wave X micro-
plate spectrophotometer at 490 nm of wavelength.
2.11. Statistical analysis
Data are expressed as the mean ± SEM of at least
three independent experiments with three replicates
each. Statistical significance was determined by a two-
tailed Student t-test and one-way ANOVA with post
hoc Tukey test as appropriate using GraphPad Prism
version 8.3.0. Results were considered significant at
p < 0.05.
3. Results and discussion
3.1. Cryogel scaffold characterization
The difficulty of obtaining pancreatic islets from
human patients or rodents conceives a big deal to
study T2D in vitro. The limited availability of primary
4
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Figure 1. General overview of the study. (a) Cryogel fabrication process scheme. Cylinder-like scaffolds were generated, placing
the prepolymer solution in a PDMS mold. After, the prepolymer solution within the mold is placed at−20 ◦C. Thus, when
material crosslinks, water–ice crystals are formed. When thawed, this ice leads to the porosity of the scaffold. (b) Images of the
cryogel scaffold when deep in water (left) and when tweezered (right), proving the mechanical resistance of the scaffold. (c) Pore
distribution using different concentrations of the material. (d) Percentage of pores in different diameter ranges according to the
concentration of the material. Of note, the higher the concentration, the higher the percentage of pores between 0 and 25 µm of
length. (e) General magnifying glass images of the scaffold structure among different material concentrations. Scale
bar= 100 µm.
pancreatic islets has prompted investigators to use cell
lines to study β-cell function to model this disease.
However, two-dimensional monolayer cell cultures
fail to recapitulate the main key characteristics of
primary β-cells. The lack of a 3D structure has been
proven to be one of the main problems associated
with decreased functionality [30]. Despite this limita-
tion, many in vitro approaches focused on generating
3D functional pancreatic tissue using hanging-drop
methods [31] or cell encapsulation into hydrogels
[13, 32]. The origin of the pancreatic cells is from
animals, cadaveric donors, or immortalized cell lines.
However, having cell aggregations of 100 µm (the
average size of a pancreatic islet) drives encapsulation
problems, such as lack of oxygen and nutrient diffu-
sion [20, 21].
Thereby, it is complicated to engineer a fully
functional pancreatic tissue. To solve the problems
exposed in β-cell obtention and cell encapsulation,
we combined clustering cell ability with cryogelation
to generate the scaffold. We developed a proper scaf-
fold for in vivomimicking of β-cells while improving
its diffusion with this approximation. These scaffolds
were generated at sub-zero temperatures. Thus, while
the material fibers crosslink between them, water–
ice crystals are formed. When thawed, these ice crys-
tals lead to empty pores (figure 1(a)). This scaffold
has a sponge-like highly interconnected structure
with a controllable pore size. This feature makes
this scaffold a good material to handle due to its
elastic properties (supplementary video 1).Moreover,
the good mechanical stability and elasticity allows
manipulating and moving the scaffold from one
place to another without breaking it or suffering any
damage (figure 1(b)).
One of the remarkable properties of cryogela-
tion is the possibility to modulate the pore size. For
this, we studied different material (gelatin and CMC)
concentrations and quantified the diameter of each
pore. Regardless of the material type, in the case of
5% (w/v), porosity ranged from 10 up to 100 µm
of diameter while in 1%, pores ranged from 10 to
150 µm and at 0.5%, pores ranged up to 200 µm
(figure 1(c)). Percentage of pores in different dia-
meter ranges according to the concentration of the
material are shown in figure 1(d). Of note, the higher
the concentration, the higher the percentage of pores
between 0 and 25 µm of length. By observing the
fiber mesh, we can note this ascendant porosity range
(figure 1(e)). Our goal was to generate β-cell aggrega-
tions thatmatch in size with primary pancreatic islets,
which are very heterogeneous in size. Therefore, the
pore distribution of our scaffold should also present
a wide range distribution. Additionally, in vivo small
pancreatic islets are more common than big ones
[33, 34]. Knowing all this, we concluded that with 1%
5
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cryogels, we achieved the porosity that suited all the
needs exposed.
3.2. CMC cryogel has good physical properties,
similar to the native pancreas
We tested two different materials to develop this new
approximation, each with various beneficial prop-
erties to aggregate β-cells. CMC is a biocompatible
biomaterial with good mechanical stability and non-
degradable by mammalian cells [35]. Importantly,
in vitro and in vivo evaluations of those cellulose-
basedmaterials have demonstrated excellent biocom-
patibility [25, 26]. The other material studied is
gelatin, a biocompatible biomaterial, biodegradable,
and with RGD cell adhesive points, but with low
mechanical stability [27]. In this case, gelatin was
selected because it was previously studied that it can
enhance pseudoislet formation [30, 36].
To prove that the pore distribution fits our needs
and does not vary between materials, we studied the
pore distribution of the 1% CMC cryogels and 1%
gelatin cryogels (figure 1(a)). We could observe that
by changing the material, the pore distribution did
not change. The pores, as expected, range from 10
up to 170 µm. Despite a high amount of small pores
found in the cryogel, big pores were also observed.
As previously reported, this pore distribution fits with
the range that we want to generate cell aggregations.
Additionally, the porosity was analyzed through
SEM images (figure 2(b)) and confocal images
(figure 2(c)). In SEM images acquired after dehyd-
ration and critical point dry, it can be observed that
pore distribution is heterogeneous, and pores from
many different sizes were formed. Following the same
tendency, in confocal images, where fibers are stained
in green, many different pore sizes can be observed,
both in CMC and gelatin cryogels (figure 2(c)). Also,
in confocal images, it can be appreciated that there are
no significant visual differences in pore size between
CMC and gelatin cryogels.
Knowing that the porosity is in the desired range
to form pseudoislets with a similar size to the in vivo,
the next step was to check our scaffold mechanical
properties. As we wanted to mimic the extracellular
matrix and the pancreatic islet environment, the stiff-
ness is an essential property. The ECM mainly has
the objective to support cells and plays an import-
ant role in cell viability and functionality by dot-
ing the cells of specific biochemical and physical sig-
nals [37]. Moreover, knowing that cells modulate
their behavior in different substrate stiffness [39, 40,
41], maintaining a similar stiffness as the pancreas
should help the cells to function and differentiate
better. Compression assays were performed to study
bulk stiffness by studying scaffolds Young modulus.
In elastic solids with a determined section and length,
the main stiffness variable is the Young modulus,
Figure 2.Mechanical characterization of the scaffold. (a)
Comparison of the pore distribution between gelatin and
CMC cryogels with the same material concentration (1%
(w/v)). (b) SEM images of the cryogel porosity. Scale
bar= 300 µm. (c) Aminofluorescein stained fibers of
gelatin (left) and CMC (right) obtained with confocal
microscopy. Scale bar= 100 µm. (d) Stiffness results from
different cryogels. (e) Swelling ratio. (f) Diffusion profile of
fluorescein through the scaffold. Results are expressed as
the mean± SEM. ∗p < 0.05, ∗∗∗∗p < 0.0001.
so studying this intensive material property we can
get trustable stiffness values. These CMC cryogel are
stiffer than gelatin (0.67± 0.08 kPa vs 0.30± 0.1 kPa)
(figure 2(d)) and the stiffness achieved correlates well
with the proper stiffness defined for pancreatic tis-
sue. As the pancreas is a soft tissue, its stiffness ranges
from 0.1 to 10 kPa [40]. The pancreas seems to
respond properly to this interval’s lower stiffness, as
6
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cells can increase insulin mRNA expression and gluc-
ose sensitivity [41]. In other approaches, the stiff-
ness of native healthy pancreas was set as approx-
imately 1 kPa when measured by magnetic reson-
ance elastography [42, 43], a value that fits with the
scaffold stiffness achieved. Also, soft scaffolds favor
cell coalescence and preserve the cluster-like organ-
ization, while in stiff substrates, the extracellular-cell
interactions cause cell scattering and loss of islet-like
structure [44].
Another feature that we wanted to improve is the
diffusion of nutrients through the scaffold. Swelling
is the water uptake capability of a hydrogel, an indir-
ect measurement of pore interconnectivity [45]. The
high pore diameter distribution and the high pore
interconnectivity, typical from cryogels, enhances
this swelling property [46]. Also, the better are these
properties, the faster diffusion among all the scaf-
fold. After only 24 h, our cryogel reached an equilib-
rium, with a swelling ratio of 98.14± 0.32% for CMC
and 96.30 ± 0.38% for gelatin cryogel (figure 2(e)).
Although this property is higher in CMC cryogels
than in gelatin, as expected, both ratios are higher
than 95%. This high percentage indicates that the
scaffold’s structure is highly interconnected, as water
could colonize all the scaffold structure after drying.
Moreover, one of the strong points of this
approach is the high diffusion of oxygen and nutri-
ents through the scaffold because high permeabil-
ity of the scaffold. A fluorescein permeation exper-
iment was performed to test scaffold features. We
could observe that the control sample, where the
transwell was placed without cryogel, reaches equi-
librium faster than the cryogels. However, these con-
ditions reached equilibrium equally after 240 min
(figure 2(f)). Calculating the scaffold’s permeability,
we obtained values of 5.72 mm s−1 in CMC cryogels
and 0.61 mm s−1 in gelatin cryogels. This difference
in permeability indicates that CMC cryogels are more
permeable than gelatin cryogels [46]. This rapid equi-
librium reached shows that the cryogel has barely any
interaction as a diffusion barrier. After 3 min, fluor-
escein can be found in the lower part of the transwell.
This high permeability ensures us to generate amicro-
porous cryogel able to sustain cells in all the scaffold’s
depths with no hypoxia or lack of nutrient problems.
We can conclude that our scaffold satisfies all the
mechanical and physical needs of the β-cells. Over-
all, these results show awell-defined and reproducible
method to afford non-degradable and microporous
cell supportive scaffold.
3.3. CMC-based scaffold enhances INS1E
pseudoislet formation
To generate a functional 3D structure able to sup-
port β-cells, we seeded INS1E cells onto the scaf-
folds. After cell seeding, INS1Emorphology was eval-
uated in gelatin and CMC-based scaffolds at days
1, 4, and 7. Interestingly, at day 1 after seeding,
instead of the typical monolayer architecture, cells
cultured in 3D CMC cryogel scaffolds formed round-
shaped clusters (figure 3(b)), morphologically resem-
bling pancreatic islets (figure 3(a)). In contrast, a dis-
persed organization was observed in gelatin-based
cryogels (figure 3(b)). The difference in cell organ-
ization observed in CMC and gelatin scaffolds can
be explained by the presence or absence of the
cell adhesion motifs in these structures. Gelatin is
known to contain RGD (arginine-glycine-aspartic
acid) motifs, cell adhesion sites found in several ECM
proteins [47]. Hence, gelatin has a profound effect
on the ability of cells to adhere to this material.
On the other hand, CMC cryogels do not present
cell-binding motifs, so it displays shallow adhesion
properties for anchorage-dependent growth of INS1E
cells, promoting cells to interact between them and to
cluster together, forming islet-like structures.
Confocal image analysis of INS1E clusters
revealed that at day 1 pseudoislets were about 60.6µm
in diameter, and they increased in size during the first
7 d, reaching an average diameter of 75.5 µm after
1 week of culture. At this point, we obtained a het-
erogeneous pseudoislet population in size, ranging
from 16.8 to 216.7 µm (figure 3(c)). Primary rodent
pancreatic islets present a considerable heterogeneity
in size and shape, varying from small cell clusters to
larger islets [48, 49]. Several studies have revealed
that islet heterogeneity influences the insulin secret-
ory response of β-cells, so heterogeneity should be
an essential consideration when understanding T2D
pathogenesis, both at a single-cell and islet level [51,
52, 53]. At day 1, up to 12% of the clusters ranged
from 0 to 25 µm, whereas at days 4 and 7, aggreg-
ations smaller than 25 µm represented less than
3% (figure 3(d)). Pseudoislets bigger than 200 µm
were only observed at day 7. Of note, percentages of
clusters higher than 25 µm diameter correlate with
those of the scaffold porous sizes (figure 1(d)), indic-
ating that cells keep proliferating until they reach the
porous diameter.
Indeed, cells within the gelatin-based cryogel
presented high proliferation rates at day 1 after seed-
ing (67.0 ± 3.9%), determined by immunostaining
of Ki67, but this ratio decreased to 46.8 ± 2.9% at
day 4 and 10.8 ± 1.6% at day 7 (figure 3(e)). This
trend was also observed in cells cultured within the
CMC-based scaffold, presenting 51.3 ± 1.6% at day
1, 17.1 ± 1.5% at day 4, and 8.0 ± 1.0% at day 7
(figure 3(f)). In rodent islets, the proliferative capacity
of β-cells is confined to the early stages of life, linked
to an immature functional phenotype [52, 53]. Thus,
reduced proliferative capacity is one of the charac-
teristics of mature β-cells, and maturation of β-cells
defines their functional identity. Therefore, a strategy
to obtain a heterogeneous population of islet cell
clusters with low proliferation capacity offers excel-
lent potential to engineer a model for the study of
β-cell function and viability.
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Figure 3. Pseudoislets generated in the scaffold have a high resemblance with primary pancreatic islets. (a) Immunostaining of
mouse primary pancreatic islets within a 1% CMC-scaffold stained for insulin (red), Ki67 (white) and nuclei (DAPI).
Aminofluorescein was used to stain the fibers of the cryogel (green). Scale bar= 100 µm. (b) Representative images of INS1E cells
inside the scaffold at days 1, 4, and 7 stained as in a. Note that INS1E cells within CMC scaffolds aggregate forming pseudoislets
already 1 d after seeding. In contrast, cells within the gelatin are spread out. Scale bar= 100 µm. (c) Diameter of the pseudoislets
on days 1, 4, and 7. (d) Diameter distribution of the pseudoislets formed inside the CMC cryogel along the week. (e) and
(f) Proliferation rate (calculated as the percentage of Ki67-positive β-cells concerning the total number of β-cells) of INS1E cells
inside the (e) gelatin cryogel and (f) CMC cryogel. Results are expressed as dot-box plots indicating the first quartile, the median,
the third quartile, and the minimum and maximum values.
3.4. CMC-based scaffold maintains cell viability
and promotes β-cell identity
Since 3D pseudoislets may have less access to nutri-
ents, it was of interest to establish cell viability
along one week of culture. Cell viability was assessed
at culture days 1, 4, and 7 by a live/dead assay
(figure 4(a)). We found that after 7 d of culture,
encapsulated cells retained their viability compared
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Figure 4. Cell viability and β-cell identity are preserved when pseudoislets are generated inside the scaffold. (a) Analysis of
live/dead INS1E cells at day 1, 4, and 7 seeded in a traditional plate and within the scaffolds. (b) Representative fluorescent images
were taken by confocal microscopy of cells seeded in a monolayer and gelatin and CMC-based scaffolds. Live cells are marked
with calcein AM in green, and dead cells are marked with EthD-1 in red. Note that cells within the CMC cryogel appear as
clusters. Scale bar= 100 µm. (c) Alamar blue test of the cells in monolayer at the plate, monolayer on the gelatin cryogel and in
the form of pseudoislets in the CMC cryogels, at days 1, 4, and 7. Data are shown relative to cells seeded in a plate. (d) Gene
expression analysis of the β-cell identity markers, MafA, Pdx1, and NeuroD1, and proliferation markers Ki67 and Pbk. Gene
expression was normalized against Tbp1. Results are expressed as mean± SEM from three independent experiments. ∗p < 0.05,
∗∗p < 0.01, ∗∗∗p < 0.001, ∗∗∗∗p < 0.0001.
to non-encapsulated cells, and both gelatin and CMC
scaffolds presented a similar percentage of viability
(figures 4(a) and (b)). Changes in viability or cell
proliferation can be easily detected with the Ala-
marBlue test. Encapsulated cells at day 7 showed
decreased metabolic activity (figure 4(c)). As no dif-
ferences were observed in cell viability (figure 4(a)),
this decreased metabolic activity correlates with a
reduced proliferation ratio, confirming our previous
results (figure 3). Overall, these results demonstrated
that the highly porous cryogels were suited for engin-
eering cell-supportive tissue scaffolds, facilitating the
diffusion of oxygen and nutrients, and enabling cell
viability for up to 7 d.
The ability of CMC scaffolds to efficiently aggreg-
ate single cells into engineered pseudoislets, with
round-shaped structures similar to native islets,
prompted us to examine the gene expression pro-
file of these pseudoislets over time compared to
gelatin-based monolayer INS1E cells and INS1E cells
cultured without a 3D scaffold. We first focused
on the genes encoding MafA, Pdx1, and NeuroD1,
three β-cell specific transcription factors (TFs)
involved in β-cell functionality. Although many
TFs have been involved in the maintenance of the
β-cell identity, these specific transcriptional reg-
ulators have been demonstrated to play a crucial
role in maintaining the function of the insulin-
producing cells. Indeed, it has been demonstrated
that these TF activates the insulin gene expression in
a coordinated and synergistic manner in response to
increased glucose levels. Furthermore, the fine-tune
regulation of these TF ensures β-cell identity
[54, 55, 58].
Interestingly, cells supported within the cellulose-
based scaffold presented a gradually increased expres-
sion level of the β-cell specific marker Pdx1 concern-
ing cells cultured in a well plate (figure 4(d)), even
though results are not statistically significant. The
results obtained are consistent with previous works
demonstrating how reaggregating cells to form 3D
spheroids significantly enhances the gene expression
profile of β-cells [56]. Similarly, recapitulating endo-
crine cell clustering in culture has been demonstrated
to foster the maturation of human stem-cell-derived
β-cells [57].
This better-differentiated phenotype of β-cells
when cultured within a 3D extracellular matrix, is
consistent with the decreased proliferation markers,
Ki67 and Pbk (figure 4(d)), corroborating the balance
between an increased β-cell identity and a reduced
ability to proliferate of these cells [52].
3.5. Cell aggregation improves GSIS and can be
used as a suitable cellular model for the study of
the β-cell function
Several findings indicate that islet architecture has
a pivotal role in determining β-cell functionality as
cell-cell interactions are fundamental for the cor-
rect cellular function [58, 59]. Indeed, it has been
described that the secretory response of structur-
ally coupled β-cells is higher than that of insulin-
producing β-cells not arranged within the islet archi-
tecture [60, 61]. INS1E cells traditionally seeded in a
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Figure 5. Pseudoislet formation enhances β-cell responsiveness to glucose. (a) Glucose-stimulated insulin secretion (GSIS) assay
at day 1, 4, and 7 in plate monolayers, gelatin cryogels, and CMC cryogels. For the GSIS assays, cells were incubated for 1 h at
2.8 mM glucose, followed by 16.7 mM glucose, and returning to basal condition (2.8 mM glucose). Results are expressed as the
percentage of insulin secreted related to the corresponding sample± SEM’s total insulin content from three independent
experiments, each one including at least three different replicates per condition. ∗p < 0.05, ∗∗p < 0.01, ∗∗∗p < 0.001,
∗∗∗∗p < 0.0001. (b) Stimulation index, calculated as the fold-change increased between the insulin secreted at basal levels (first
incubation with 2.8 mM glucose) and after challenging the cells with 16.7 mM glucose. Results are expressed as the mean± SEM.
monolayer do not present reproducible responses to
dynamic glucose stimulations [6].
To determine whether pseudoislet formation
within the cryogel correlates with increased β-cell
function, we tested the dynamic response of pseudois-
lets to glucose. To check islet functionality, a GSIS
assay, which defines the ability of β-cells to secrete
the suitable amount of insulin in response to propor-
tional extracellular glucose stimuli, was performed in
all conditions. As shown in figure 5(a), cell cluster-
ing improved the insulin secretion stimulation index
under high glucose stimulation concerning the basal
insulin secreted in low glucose conditions. This res-
ult demonstrates the benefit of cell aggregation in
islet functionality. For primary islets of Langerhans,
a threshold stimulation index of at least five defines
a functional response, and often immortalized β-cell
lines do not reach this threshold level or display a
reproducible behavior. Indeed, at day 1, INS1E cells
seeded in a 48 well-plate presented a 2.51 ± 0.6 fold
increase of insulin secretion when cells were chal-
lenged with 16.7 mM compared to cells incubated
with 2.8 mM glucose. Cells seeded in gelatin cryogels
showed a 6.47 ± 1.8 fold increase. Interestingly, we
reached a fold increase of 7.52 ± 1.6 of insulin secre-
tion when CMC-based pseudoislets were challenged
with 16.7 mM glucose. This trend was repeated along
the week, indicating that the stimulation index for
insulin response to glucose is significantly higher in
pseudoislets than dispersed and non-organized cells
(figure 5(b)).
Like other tissues, β-cell functionality is greatly
influenced by cell-cell and cell-matrix interactions,
controlling basal and stimulated insulin secretion
[62, 63]. Remarkably, GSIS defects in monolayer
INS1E cell cultures arise from an increased insulin
release under basal conditions (2.8 mM glucose) in
addition to a decreased insulin secretory response
under stimulatory glucose conditions. These res-
ults are consistent with other studies showing that
aggregating β-cells enhances the secretory respons-
iveness to nutrients comparedwith cells configured as
monolayers. And it also suggests that β-cells interac-
tions might be sufficient to sustain a normal glucose
response.
Therefore, our study validates that a correct struc-
tural arrangement is essential for appropriate insulin
response, demonstrating a robust GSIS by pseudois-
lets formed within a cryogel.
4. Conclusions
An increasing need to engineer advanced 3D scaffolds
for tissue engineering has emerged to provide cellular
structural support and mimic the complicated phys-
ical and biochemical properties of the native extracel-
lular matrix. With this improvement, more resemb-
lance tissues can be engineered for many applications
as drug screening or disease modeling. Until now,
many tissues have been generated in the laboratory.
Particular attention must be paid when engineering
islet-like structures as an adequate round-shaped islet
architecture is necessary to maintain and improve
β-cell functionality. Moreover, the formation of islet-
like structures or pseudoislets, with the consequent
β-cell communications, is required for an appropri-
ate insulin secretory response [64, 65].
Traditionally, pancreatic islets have been encap-
sulated inside hydrogels, generating a scaffold with
interesting properties [13, 32, 66, 67], but lack-
ing oxygen and nutrient diffusion throughout all
the scaffold. This decreased diffusion rate usually
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results in an impaired GSIS profile. In this sense,
cryogels appeared as interesting alternatives [24], as
they present high pore sizes and therefore better
permeation ability. Additionally, cryogels present a
strong potential to aggregate single cells into a pseu-
doislet architecture [24, 56, 68]. Other studies have
already exhibited the feasibility of aggregating pan-
creatic β-cells into microporous scaffolds, however
most of them do not reproduce the islet function-
ality [69, 70, 72, 73] or obviate the role of the 3D
microenvironment, not mimicking the physiological
environment of the pancreatic islets [5, 56, 58, 71].
And even though previous studies have used other
materials such as electrospung gelatin scaffolds to
generate ∼100 µm pseudoislets surrounded with a
matrix and with promising insulin secretion [30],
to the best of our knowledge this is the first study
usingCMCscaffolds to generate viable and functional
pseudoislets.
This study reports a new CMC cryogel scaffold
that favors pseudoislet generation and functionality.
Here, we proved that the cryogelation allows to gen-
erate a sponge-like scaffold with controllable struc-
tural properties. We demonstrated that we can cre-
ate and modulate a wide range of porosity that fits
with primary pancreatic islets’ size and shape. Our
scaffold’s diffusion and permeability overcome some
of the most problematic conditions, such as the lack
of nutrient and oxygen diffusion through all the scaf-
fold.Moreover, themechanical properties of the cryo-
gels match with the previously reported stiffness of
the native pancreas ranging around 1 kPa. All these
properties of cryogels favor the viability of the β-cells,
promote their β-cell identity and increase their gluc-
ose responsiveness.
In summary, in this study, we have generated
a new approximation to engineer pancreatic tis-
sue, combining the cryogelation technique with cell
aggregation in microporous scaffolds. Because cell
clustering improves β-cell identity and functionality,
our results demonstrated the feasibility of using these
microporous gel materials as 3D scaffolds culturing
islet-like cell aggregates as an in vitro model to study
T2D and other related diseases.
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